Juvenile Arthritis News

Children with juvenile idiopathic arthritis were safely treated with high doses of infliximab, according to recent study results.

Intravenous laser blood irradiation and etanercept therapy were more effective than a placebo laser treatment with etanercept in improving core symptoms of juvenile idiopathic arthritis, according to recent study results.

Patients with juvenile idiopathic arthritis and their parents identified and proposed five major areas of concern regarding pediatric rheumatology care and service delivery in a recent study.

The measles-mumps-rubella vaccination in children with juvenile idiopathic arthritis compared with no booster did not result in worsened juvenile idiopathic arthritis disease activity and was immunogenic, according to recent study findings published in The Journal of the American Medical Association.

The measles-mumps-rubella vaccination in children with juvenile idiopathic arthritis compared with no booster did not result in worsened juvenile idiopathic arthritis disease activity and was immunogenic, according to recent study findings published in The Journal of the American Medical Association.

Four novel autoantibody biomarkers could significantly improve diagnoses of rheumatoid arthritis, according to research presented at the annual congress of the European League Against Rheumatism in Madrid.

Successful tapering of corticosteroid use was achieved for almost half the patients with systemic juvenile idiopathic arthritis through canakinumab therapy in a study presented at the annual congress of the European League Against Rheumatism in Madrid.

A significant proportion of children with juvenile idiopathic arthritis had difficulties with their methotrexate regimens that adversely affected their health-related quality of life, according to recent study results.

Adalimumab had better efficacy when used as the first anti-tumor necrosis factor-alpha treatment for childhood chronic uveitis than when used after infliximab failed, according to study results.

Patients with juvenile psoriatic arthritis experienced good long-term outcomes and did not appear to form a distinct patient subset, instead resembling juvenile idiopathic arthritis patients with onset types excluding psoriasis, according to study results.